BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22964946)

  • 1. Risks for infection in patients with myelodysplasia and acute leukemia.
    Pagano L; Caira M
    Curr Opin Infect Dis; 2012 Dec; 25(6):612-8. PubMed ID: 22964946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
    Merkel D; Filanovsky K; Gafter-Gvili A; Vidal L; Aviv A; Gatt ME; Silbershatz I; Herishanu Y; Arad A; Tadmor T; Dally N; Nemets A; Rouvio O; Ronson A; Herzog-Tzarfati K; Akria L; Braester A; Hellmann I; Yeganeh S; Nagler A; Leiba R; Mittelman M; Ofran Y
    Am J Hematol; 2013 Feb; 88(2):130-4. PubMed ID: 23345248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacteremia caused by Kocuria kristinae in a patient with acute leukaemia].
    Martinaud C; Gaillard T; Brisou P; Gisserot O; de Jaureguiberry JP
    Med Mal Infect; 2008 Mar; 38(3):165-6. PubMed ID: 18191518
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
    El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
    Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].
    Zupanić-Krmek D; Nemet D; Mrsić M; Bogdanić V; Labar B; Jandrlić M; Kalenić S
    Acta Med Croatica; 2004; 58(4):275-84. PubMed ID: 15700683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection and hemorrhage in elderly acute myeloblastic leukemia and primary myelodysplasia.
    Barbui T; Cortelazzo S; Viero P; Buelli M; Bassan R
    Hematol Oncol; 1993; 11 Suppl 1():15-8. PubMed ID: 7683621
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic fusarioses in immunodeficient patients].
    Dermoumi H; Petrasch S; Quabeck K
    Med Klin (Munich); 1990 Mar; 85 Suppl 1():166-70. PubMed ID: 2342444
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of micafungin as an empirical antifungal agent for febrile neutropenic patients with hematological diseases.
    Park JS; Kim DH; Choi CW; Jeong SH; Choi JH; Kim K; Kim SJ; Jung CW; Yang DH; Jang JH
    Acta Haematol; 2010; 124(2):92-7. PubMed ID: 20664196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelodysplastic syndrome developing acute myelocytic leukemia with gastric mucormycosis].
    Sasaki A; Tsukaguchi M; Takayasu K; Hanai J
    Rinsho Byori; 1993 Sep; 41(9):1054-8. PubMed ID: 8254969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
    Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
    Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy.
    Mattiuzzi GN; Kantarjian H; O'Brien S; Kontoyiannis DP; Giles F; Zhou X; Lim J; Bekele BN; Faderl S; Cortes J; Pierce S; Leitz GJ; Raad I; Estey E
    Cancer; 2004 Feb; 100(3):568-73. PubMed ID: 14745874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia.
    Bernardeschi P; Bonechi I
    Recenti Prog Med; 1991 Nov; 82(11):588-90. PubMed ID: 1763231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.
    Cordonnier C; Mohty M; Faucher C; Pautas C; Robin M; Vey N; Monchecourt F; Mahi L; Ribaud P
    Int J Antimicrob Agents; 2008 Feb; 31(2):135-41. PubMed ID: 18162375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis.
    Mahoney DH; McClain KL; Hanson IC; Taylor LD; Steuber CP
    Am J Pediatr Hematol Oncol; 1989; 11(2):153-7. PubMed ID: 2546462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bernard-Soulier-like functional platelet defect in myelodysplastic syndrome and in acute myeloblastic leukemia associated with trilineage myelodysplasia.
    Hiçsönmez G; Gümrük F; Cetin M; Ozbek N; Tuncer M; Gürsel T
    Turk J Pediatr; 1995; 37(4):425-9. PubMed ID: 8560614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant.
    Hale KA; Shaw PJ; Dalla-Pozza L; MacIntyre CR; Isaacs D; Sorrell TC
    Br J Haematol; 2010 Apr; 149(2):263-72. PubMed ID: 20096013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis.
    Patel LM; Maghari A; Schwartz RA; Kapila R; Morgan AJ; Lambert WC
    Int J Dermatol; 2012 Apr; 51(4):383-8. PubMed ID: 22435424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.